Sensitive women and stoical men are the prevalent images of people in chronic pain. Unwarranted differences in medical treatment may result, as a University of Gothenburg doctoral thesis emphasizes.

Fibromyalgia is a mysterious chronic pain disorder that is difficult to treat. Its causes are also still largely in the dark.

When I first took on the role as the American College of Rheumatology (ACR) Committee on Government Affairs chair, I was keenly aware of being the first woman to be nominated to this position. While the demographics of government officials have changed over the past several decades, governance positions are held overwhelmingly by men. Having my voice heard and advocating for my colleagues at the ACR, and most importantly for our patients, were priorities. 

BRIDGE-PMR proof-of-concept trial assessed the efficacy of rituximab (RTX) in patients with polymyalgia rheumatica (PMR) and showed that a single 1000 mg dose of lead to a significant number of glucocorticoid-free remissions after 1 year. 

British Society for Rheumatology (BSR) last published its guideline for systemic sclerosis (SSc) in 2016. Given the many advances in the field the BSR has outlined their plans to update the management of SSc.